×
切換帳號
FAQ
新手指南
FAQ常見問題
學術會議
影音網
登入
×
全站搜尋
搜尋
台灣泌尿科醫學會E-School
登入
FAQ
新手指南
FAQ常見問題
學術會議
影音網
到官網
Home
到官網
Home
媒體:
233
建立:
2022/03/17
管理者:
系統管理者, TUA秘書處, TUA會計採購組, TUA學術資訊組, TUA出納客服組, TUA會議組
搜尋這個資料夾
媒體
(233)
討論區
(0)
常見 Q&A
(0)
知識庫
...
2022年會
摘要
媒體
摘要
摘要
管理者:系統管理者, TUA秘書處, TUA會計採購組, TUA學術資訊組, TUA出納客服組, TUA會議組
人氣
討論
發表人
上傳日期
標題
1.
Podium
897
0
TUA會計採購組
2022-06-07
1.1
PD01-1: A genome-wide association study (GWAS) of kidney stone disease in the Taiwanese population.
人氣: 897, 討論: 0, 發表人: TUA會計採購組, 上傳時間: 2022-06-07
741
0
TUA人資客服組
2022-06-07
1.2
PD01-2: The sodium-glucose cotransporter-2 inhibitor dapagliflozin inhibit kidney stone formation through modulating AMPK-mediated autophagy
人氣: 741, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
611
0
TUA人資客服組
2022-06-07
1.3
PD01-3: Urine NT-probnp as a non-invasive indicator for recovery of renal function after receiving ureteroscopic surgery aiming at relieving hydronephrosis
人氣: 611, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
651
0
TUA人資客服組
2022-06-07
1.4
PD01-4: Comparison of surgical outcomes between ultramini-endoscopic combined intrarenal surgery and retrograde intrarenal surgery
人氣: 651, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
793
0
TUA人資客服組
2022-06-07
1.5
PD01-5: Comparative analysis of simultaneous supine percutaneous nephrolithotomy with ureteroscopic lithotripsy and retrograde intrarenal surgery in the management of large proximal ureteral calculi
人氣: 793, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
590
0
TUA人資客服組
2022-06-07
1.6
PD01-6: Comparison of mini endoscopic combined intrarenal surgery and multitract percutaneous nephrolithotomy specifically for kidney staghorn stones: A single-center experience
人氣: 590, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
752
0
TUA人資客服組
2022-06-07
1.7
PD02-1: Mir-299-3p inhibits cell proliferation, motility and invasion through VEGFA in upper tract urothelial carcinoma
人氣: 752, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
732
0
TUA人資客服組
2022-06-07
1.8
PD02-2: The prognostic significance of ROR2 expression in patients with urothelial carcinoma
人氣: 732, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
748
0
TUA人資客服組
2022-06-07
1.9
PD02-3: Decreased Dehydrogenase/Reductase 2(DHRS2) expression is associated with poor prognosis in urothelial carcinoma patients
人氣: 748, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
627
0
TUA人資客服組
2022-06-07
1.10
PD02-04: Outcomes of chemotherapy agents as subsequent replacements for discontinued bacillus calmette-guerin bladder instillation in bladder cancer
人氣: 627, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
760
0
TUA人資客服組
2022-06-07
1.11
PD02-5: Predictive factors of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma
人氣: 760, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
747
0
TUA人資客服組
2022-06-07
1.12
PD02-6: The therapeutic potential of chemoradiotherapy combine with regional hyperthermia therapy for locally advanced bladder cancer- phase III clinical trial preliminary data report
人氣: 747, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
659
0
TUA人資客服組
2022-06-07
1.13
PD03-01: The occurrence of inguinal hernia after robotic assisted radical prostatectomy: Clinical characteristics and associated risk factors
人氣: 659, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
659
0
TUA人資客服組
2022-06-07
1.14
PD03-02: Comparing the perioperative outcomes between hand-assisted laparoscopic partial nephrectomy and laparoscopic partial nephrectomy
人氣: 659, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
648
0
TUA人資客服組
2022-06-07
1.15
PD03-03: Outcome of robotic radical cystectomy with intracorporeal J-pouch neobladder in muscle-invasive bladder cancer patient
人氣: 648, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
641
0
TUA人資客服組
2022-06-07
1.16
PD03-04: Loss of MAEL expression sabotages mitochondrial function and impairs human sperm motility
人氣: 641, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
646
0
TUA人資客服組
2022-06-07
1.17
PD03-05: The relationship between antioxidative ingredients of traditional chinese medicine and semen quality in men with infertility
人氣: 646, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
678
0
TUA人資客服組
2022-06-07
1.18
PD03-06: Combining sperm DNA fragmentation index with computer-assisted semen morphokinematic parameters as a better window into male fertility
人氣: 678, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
652
0
TUA人資客服組
2022-06-07
1.19
PD04-01: Active surveillance in Taiwanese men with localized prostate cancer: Outcomes and predicting models
人氣: 652, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
651
0
TUA人資客服組
2022-06-07
1.20
PD04-02: Overall survival with Darolutamide versus placebo in combination with androgen-deprivation therapy and Docetaxel for metastatic hormone-sensitive prostate cancer in the phase 3 ARASENS trial
人氣: 651, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
629
0
TUA人資客服組
2022-06-07
1.21
PD04-03: The role of urine metabolomics in predicting clinically significant prostate cancer
人氣: 629, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
573
0
TUA人資客服組
2022-06-07
1.22
PD04-04: Comparison of the clinical outcomes of chemotherapy and novel hormone agents in pre-chemotherapy and post-chemotherapy settings for treatment of metastatic castration-resistant prostate cancer
人氣: 573, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
603
0
TUA人資客服組
2022-06-07
1.23
PD04-05: Prostate health index density outperforms prostate health index in clinically significant prostate cancer detection
人氣: 603, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
646
0
TUA人資客服組
2022-06-07
1.24
PD04-06: 4-year experience in cmuh for learning curve of MRI/Ultrasound fusion-guided prostate biopsy
人氣: 646, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
604
0
TUA人資客服組
2022-06-07
1.25
PD05-01: Clinical factors that influence the occurrence of renal artery pseudoaneurysms after robotic assisted partial nephrectomy: Single center study of renal function outcomes
人氣: 604, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
599
0
TUA人資客服組
2022-06-07
1.26
PD05-02: Prognostic factors of disease progression in patients with locally advanced renal cell carcinoma
人氣: 599, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
582
0
TUA人資客服組
2022-06-07
1.27
PD05-03: Early postoperative outcomes of retroperitoneal partial nephrectomy of anterior and posterior renal tumors: A five-year experience in a single center
人氣: 582, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
633
0
TUA人資客服組
2022-06-07
1.28
PD05-04: The prevalence and association of complicated ureteral double-J stent exchange in patients with malignant ureteral obstruction: A single-center, 20 years retrospective study
人氣: 633, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
575
0
TUA人資客服組
2022-06-07
1.29
PD05-05: The safety and efficacy of endoscopic resection of bladder tumor with vela laser– a single center experience
人氣: 575, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
814
0
TUA人資客服組
2022-06-07
1.30
PD05-06: Does surgical experience influence the oncological outcome following hand-assisted or pure laparoscopic transperitoneal nephroureterectomy for primary upper urinary tract urothelial carcinoma in Taiwan
人氣: 814, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
625
0
TUA人資客服組
2022-06-07
1.31
PD06-01: The effect of hyper-sugar situation and LCN2 treatment to the uropathogenic escherichia coli infection and induced inflammation in bladder cells
人氣: 625, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
556
0
TUA人資客服組
2022-06-07
1.32
PD06-02: The reconstruction of severe type hypospadias with sandwich technique-sharing the experience of CCH in recent 30 years
人氣: 556, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
590
0
TUA人資客服組
2022-06-07
1.33
PD06-03: Treatment response of nocturnal enuresis children: A study of interdepartmental prescription and responses in Taiwan
人氣: 590, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
598
0
TUA人資客服組
2022-06-07
1.34
PD06-04: Deep fascia YV scrotoplasty for correcting buried penis in children
人氣: 598, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
591
0
TUA人資客服組
2022-06-07
1.35
PD06-05: Native hydronephrosis after kidney transplantation relates to urinary bladder urothelial carcinoma: A single center study
人氣: 591, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
758
0
TUA人資客服組
2022-06-07
1.36
PD06-06: Comparing the different definition of delayed graft function after renal transplantation
人氣: 758, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
578
0
TUA人資客服組
2022-06-07
1.37
PD07-01: The effects of inhibition and activation of TMEM16A calcium-activated chloride channels on the smooth muscle tissue in metabolic syndrome induced overactive bladder and acontractile detrusor
人氣: 578, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
622
0
TUA人資客服組
2022-06-07
1.38
PD07-02: Ebv-mediated BDNF expression in B cells is causally linked to the persistence of hic-induced pathogenesis
人氣: 622, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
641
0
TUA人資客服組
2022-06-07
1.39
PD07-03: Endoscopic intravesical repair as a feasible and promising approach for vesicovaginal fistula
人氣: 641, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
741
0
TUA人資客服組
2022-06-07
1.40
PD07-04: Therapeutic effect of low intensity extracorporeal shock wave therapy (Li-ESWT) on diabetic bladder dysfunction in a rat model
人氣: 741, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
628
0
TUA人資客服組
2022-06-07
1.41
PD07-05: Does COVID-19 vaccine deteriorate storage lower urinary tract symptoms?
人氣: 628, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
568
0
TUA人資客服組
2022-06-07
1.42
PD07-06: The role of the angle of spinning top urethra in females with dysfunctional voiding
人氣: 568, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
614
0
TUA人資客服組
2022-06-07
1.43
PD08-01: Comparison of bacterial cultures in urine and semen after prostate massage in patients with chronic prostatitis/chronic pelvic pain syndrome
人氣: 614, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
635
0
TUA人資客服組
2022-06-07
1.44
PD08-02: Therapeutic effects of low-intensity extracorporeal shock wave therapy on overactive bladder
人氣: 635, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
631
0
TUA人資客服組
2022-06-07
1.45
PD08-03: Concomitant detrusor and external urethral sphincter botulinum Toxin-A injections in male spinal cord injury patients with detrusor overactivity and detrusor sphincter dyssynergia
人氣: 631, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
592
0
TUA人資客服組
2022-06-07
1.46
PD08-04: The role of plasma angiotensin-converting enzyme 2 in primary aldosteronism
人氣: 592, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
713
0
TUA人資客服組
2022-06-07
1.47
PD08-05: New-onset Diabetic Mellitus Associated with Concurrent Autonomous Cortisol Secretion in Patients with Primary Aldosteronism
人氣: 713, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
622
0
TUA人資客服組
2022-06-07
1.48
PD08-06: Congenital Collagenopathy Increased the Risk of Inguinal Hernia-A Longitudinal Cohort Study
人氣: 622, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
608
0
TUA人資客服組
2022-06-07
1.49
PD09-01: The real-world outcome with Abiraterone acetate plus prednisone in asian men with metastatic castrate-resistant prostate cancer treated in China Medical University Hospital
人氣: 608, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
610
0
TUA人資客服組
2022-06-07
1.50
PD09-02: Preoperative MRI and clinical factors are predictors for biochemical recurrence in high and very high risk prostate cancer
人氣: 610, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
580
0
TUA人資客服組
2022-06-07
1.51
PD09-03: Could 18F-FluciclovinePET/CT be a game changer in prostate cancer with biochemical recurrence?
人氣: 580, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
694
0
TUA人資客服組
2022-06-07
1.52
PD09-04: Efficacy of immune check point inhibitors in metastatic urothelial carcinoma is associated with chemotherapy response, a real world retrospective study
人氣: 694, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
600
0
TUA人資客服組
2022-06-07
1.53
PD09-05: Perineural invasion can predict prognosis for upper tract urothelial carcinoma following radical nephroureterectomy
人氣: 600, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
617
0
TUA人資客服組
2022-06-07
1.54
PD09-06: Initial antibiotics choice may not be associated with the prognosis of fournier’s gangrene
人氣: 617, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
2.
Moderated Poster
587
0
TUA人資客服組
2022-06-07
2.1
MP01-01: Can we use urinary biomarkers to identify occult detrusor overactivity in women with stress urinary incontinence?
人氣: 587, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
579
0
TUA人資客服組
2022-06-07
2.2
MP01-02: Association with female stress urinary incontinence and sarcopenia defined by bioelectrical inpedance analysis
人氣: 579, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
580
0
TUA人資客服組
2022-06-07
2.3
MP01-03: Transvaginal ultrasound shear wave elastography to evaluate detrusor wall of bladder pain syndrome in women: A preliminary report
人氣: 580, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
584
0
TUA人資客服組
2022-06-07
2.4
MP01-04: Therapeutic efficacy of biofeedback pelvic floor muscle exercise in women with dysfunctional voiding
人氣: 584, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
579
0
TUA人資客服組
2022-06-07
2.5
MP01-05: Use cluster analysis to develop an accurate and practical diagnostic method for detrusor underactivity in female patient without bladder outlet obstruction
人氣: 579, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
538
0
TUA人資客服組
2022-06-07
2.6
MP01-06: Type D personality is a predictor of worse quality of life in women with non-neurogenic voiding dysfunction
人氣: 538, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
564
0
TUA人資客服組
2022-06-07
2.7
MP01-07: Therapeutic outcome of active management in male patients with detrusor underactivity based on clinical diagnosis and videourodynamic classification
人氣: 564, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
634
0
TUA人資客服組
2022-06-07
2.8
MP01-08: Treatment outcomes of detrusor underactivity in women based on clinical and videourodynamic characteristics
人氣: 634, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
565
0
TUA人資客服組
2022-06-07
2.9
MP01-09: Therapeutic efficacy and cognitive adverse events of overactive bladder medication in patients with central nervous system disorders- a cohort study
人氣: 565, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
647
0
TUA人資客服組
2022-06-07
2.10
MP01-10: Mirabegron is more tolerable than solifenacin in sjogren’s syndrome patients with overactive bladder symptoms
人氣: 647, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
592
0
TUA人資客服組
2022-06-07
2.11
MP02-01: Robotic-assisted radical nephroureterectomy with bladder cuff excision using Da Vinci Xi Vs. Si System: Are there any differences?
人氣: 592, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
665
0
TUA人資客服組
2022-06-07
2.12
MP02-02: Laparoendoscopic single-site inguinal herniorrhaphy: Single-institute experience and the outcome comparison of obesity
人氣: 665, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
602
0
TUA人資客服組
2022-06-07
2.13
MP02-03: Ureteral reconstruction for patient with ureteral stricture in more challenging situations
人氣: 602, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
554
0
TUA人資客服組
2022-06-07
2.14
MP02-04: The application of hybrid or in the surgery for multiple-times recurrence of adrenal cortical carcinoma
人氣: 554, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
600
0
TUA人資客服組
2022-06-07
2.15
MP02-05: The peak systolic velocity of the penile artery might indicate the risk of cardiovascular disease in patients with erectile dysfunction
人氣: 600, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
558
0
TUA人資客服組
2022-06-07
2.16
MP02-06: The more veins ligated intraoperatively; the more pain improved postoperatively after microsurgical varicocelectomy
人氣: 558, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
668
0
TUA人資客服組
2022-06-07
2.17
MP02-07: Investigating the clinical utility of three sperm chromatin dispersion (SCD) assays for sperm DNA fragmentation in male infertility
人氣: 668, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
587
0
TUA人資客服組
2022-06-07
2.18
MP02-08: An innovative combination of penile corporeal girth enhancement and erection restoration
人氣: 587, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
544
0
TUA人資客服組
2022-06-07
2.19
MP02-09: A better method to estimate ureter length in patient who needs DBJ stenting by a formula
人氣: 544, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
541
0
TUA人資客服組
2022-06-07
2.20
MP02-10: Overall survival and techenque survival in elderly peritoneal dialysis patients
人氣: 541, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
569
0
TUA人資客服組
2022-06-07
2.21
MP03-01: Treatment strategy for dialysis patient with urothelial carcinoma
人氣: 569, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
719
0
TUA人資客服組
2022-06-07
2.22
MP03-02: The pan-immune-inflammation value is a new prognostic biomarker in upper tract urothelial carcinoma
人氣: 719, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
547
0
TUA人資客服組
2022-06-07
2.23
MP03-03: New treatment strategies for overcoming the chemoresistance of urothelial carcinoma
人氣: 547, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
571
0
TUA人資客服組
2022-06-07
2.24
MP03-04: Cost-effectiveness analysis of immune checkpoint inhibitors in metastatic urothelial cancer, a single-center retrospective study
人氣: 571, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
721
0
TUA人資客服組
2022-06-07
2.25
MP03-05: Aquaporins are involved in tumor formation and may potentially act as a therapeutic target in urothelial carcinoma
人氣: 721, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
578
0
TUA人資客服組
2022-06-07
2.26
MP03-06: Effects of variant histology on the oncology outcomes of patients with upper tract urothelial carcinoma after radical nephroureterectomy
人氣: 578, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
577
0
TUA人資客服組
2022-06-07
2.27
MP03-07: The role of lymph node dissection in patients with upper tract urothelial carcinoma without clinical lymph node metastasis undergoing radical nephroureterectomy
人氣: 577, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
531
0
TUA人資客服組
2022-06-07
2.28
MP03-08: Blockade of the autophagic flux suppresses antitumor immunity via programmed death ligand-1 up-regulation in bladder cancer
人氣: 531, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
580
0
TUA人資客服組
2022-06-07
2.29
MP03-09: Second primary malignancy risk in patients with upper urinary tract urothelial carcinoma in Taiwan - a nationwide population-based study
人氣: 580, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
556
0
TUA人資客服組
2022-06-07
2.30
MP03-10: Establishing predictive model of renal function after unilateral nephroureterectomy in upper tract urothelial carcinoma patients
人氣: 556, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
699
0
TUA人資客服組
2022-06-07
2.31
MP04-01: A novel prediction of uric acid component in nephrolithiasis using simple clinical information: A machine learning-based model
人氣: 699, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
614
0
TUA人資客服組
2022-06-07
2.32
MP04-02: Genetic polymorphisms of MnSOD modify the impacts of environmental melamine on oxidative stress and early kidney injury in calcium urolithiasis patients
人氣: 614, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
566
0
TUA人資客服組
2022-06-07
2.33
MP04-03: Analysis of renal hematoma after extracorporeal shock wave lithotripsy
人氣: 566, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
564
0
TUA人資客服組
2022-06-07
2.34
MP04-04: The impact of climate factors on the prevalence of urolithiasis and the trend of the urinary stone disease management in southern Taiwan
人氣: 564, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
579
0
TUA人資客服組
2022-06-07
2.35
MP04-05: Betel nut chewing is related to the risk of kidney stone disease
人氣: 579, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
594
0
TUA人資客服組
2022-06-07
2.36
MP04-06: Can hounsfield unit of preoperative non-contrast computed tomography be used to predict calcium urinary stone composition?
人氣: 594, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
577
0
TUA人資客服組
2022-06-07
2.37
MP04-07: The impact of secondhand smoke on the development of kidney stone disease is not inferior to that of smoking
人氣: 577, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
573
0
TUA人資客服組
2022-06-07
2.38
MP04-08: Experimental observation of isolative efficacy of solid coupling medium in extracorporeal shock wave lithotripsy
人氣: 573, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
568
0
TUA人資客服組
2022-06-07
2.39
MP04-09: Comparison of the clinical outcome and treatment cost of proximal ureteral stone removal requiring multiple initial ureteroscopic lithotripsy or extracorporeal shock wave lithotripsy procedures
人氣: 568, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
579
0
TUA人資客服組
2022-06-07
2.40
MP04-10: Risk factors of infectious complications after retrograde intrarenal surgery with holmium laser for renal stones
人氣: 579, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
577
0
TUA人資客服組
2022-06-07
2.41
MP05-01: Survival impact of nephroureterectomy for de novo stage IV (nonmetastatic and metastatic) upper tract urothelial carcinoma
人氣: 577, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
573
0
TUA人資客服組
2022-06-07
2.42
MP05-02: Melatonin suppresses tumor malignancy through the NF-KB/P65/HIF-1a pathway in urothelial carcinoma
人氣: 573, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
494
0
TUA人資客服組
2022-06-07
2.43
MP05-03: Influence of novel inflammatory biomarkers on prediction for patients with upper tract urothelial carcinoma
人氣: 494, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
720
0
TUA人資客服組
2022-06-07
2.44
MP05-04: Effect of Metformin on overall survival of upper tract urothelial carcinoma in patients with type 2 diabetes
人氣: 720, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
669
0
TUA人資客服組
2022-06-07
2.45
MP05-05: Clinical outcomes of plasmacytoid urothelial carcinoma of urinary bladder: A single institution experience
人氣: 669, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
589
0
TUA人資客服組
2022-06-07
2.46
MP05-06: Validation of neutrophil to lymphocyte ratio for prognosis and treatment selection in muscle invasive bladder cancer: A single-institutional longitudinal study
人氣: 589, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
560
0
TUA人資客服組
2022-06-07
2.47
MP05-07: Demethoxycurcumin induces apoptosis in HER2 overexpressing bladder cancer cells through degradation of HER2 and inhibiting the PI3K/Akt pathway
人氣: 560, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
575
0
TUA人資客服組
2022-06-07
2.48
MP05-08: Efficiency and prognosis of enucleation turbt versus traditional turbt– VGHTC experience
人氣: 575, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
508
0
TUA人資客服組
2022-06-07
2.49
MP05-09: Suppression of tumor characteristics of urothelial carcinoma cells by berberrubine and resveratrol by GSTM2 induction
人氣: 508, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
600
0
TUA人資客服組
2022-06-07
2.50
MP05-10: Thrombospondin-4 induces lymphangiogenesis by lymphatic endothelial cell recruitment in bladder tumor
人氣: 600, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
534
0
TUA人資客服組
2022-06-07
2.51
MP06-01: Is extraperitoneal extended pelvic lymph node dissection adequate during robotic assisted radical prostatectomy for intermediate and high risk localized prostate cancer?
人氣: 534, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
560
0
TUA人資客服組
2022-06-07
2.52
MP06-02: A single center experience of Abiraterone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel based chemotherapy
人氣: 560, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
549
0
TUA人資客服組
2022-06-07
2.53
MP06-03: Real world experience of androgen deprivation therapy associated bone fracture risk in newly diagnosed prostate cancer patients
人氣: 549, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
695
0
TUA人資客服組
2022-06-07
2.54
MP06-04: Hyperforin induces extrinsic/intrinsic apoptosis signaling and inhibits NF-кB for metastasis suppression in prostate cancer cells
人氣: 695, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
582
0
TUA人資客服組
2022-06-07
2.55
MP06-05: Retzius-sparing robot-assisted radical prostatectomy and extended pelvic lymph node dissection for very high-risk prostate cancer
人氣: 582, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
523
0
TUA人資客服組
2022-06-07
2.56
MP06-06: The analysis of concordance rates between cancer stage of MR/US fusion prostate biopsy and radical prostatectomy specimen
人氣: 523, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
545
0
TUA人資客服組
2022-06-07
2.57
MP06-07: Oncological and functional outcomes in high risk and very high risk prostate cancer patients receiving robotic-assisted radical prostatectomy
人氣: 545, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
592
0
TUA人資客服組
2022-06-07
2.58
MP06-08: Treatment strategy and systemic review with PSMA PET/CT scan in progressive advanced prostate cancer
人氣: 592, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
520
0
TUA人資客服組
2022-06-07
2.59
MP06-09: KCGMH experience and meta-analysis: 6-cycle complete rate of Radium-223 therapy in Mcrpc patients with different treatment sequences
人氣: 520, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
582
0
TUA人資客服組
2022-06-07
2.60
MP06-10: Characteristics of mCRPC patients received Abiraterone acetate plus prednisolone and Enzalutamide before chemotherapy
人氣: 582, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
609
0
TUA人資客服組
2022-06-07
2.61
MP07-01: The therapeutic effects of peptide decoy-loaded hydrogel in mice with bladder outlet obstruction-induced bladder injury
人氣: 609, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
547
0
TUA人資客服組
2022-06-07
2.62
MP07-02: Therapeutic efficacy of 180-W greenlight xps vaporization of the prostate for the storage symptoms concomitant with benign prostatic obstruction and a search for outcome predictors
人氣: 547, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
548
0
TUA人資客服組
2022-06-07
2.63
MP07-03: Factors associated with the usage of alpha-blockers and overactive bladder medicines after transurethral resection of prostate
人氣: 548, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
607
0
TUA人資客服組
2022-06-07
2.64
MP07-04: Preliminary analysis of registered clinical trials for prostatic artery embolization in prostate disease
人氣: 607, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
580
0
TUA人資客服組
2022-06-07
2.65
MP07-05: Does irrigation solution affect visual field clarity during adenoma morcellation in thulium laser enucleation of the prostate: A prospective randomized pilot study
人氣: 580, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
526
0
TUA人資客服組
2022-06-07
2.66
MP07-06: Ureteral access sheath insertion failure and correlation with prediction factors in retrograde intrarenal surgery
人氣: 526, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
548
0
TUA人資客服組
2022-06-07
2.67
MP07-07: Management of renal and proximal ureteral calculi: A three-year single-center experience of retrograde intrarenal surgery
人氣: 548, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
660
0
TUA人資客服組
2022-06-07
2.68
MP07-08: The reason why patient return to emergency department following ureteroscopic lithotripsy
人氣: 660, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
685
0
TUA人資客服組
2022-06-07
2.69
MP07-09: Transurethral approach for vesicovaginal fistula(VVF) repair?- a less invasive method with preliminary outcome
人氣: 685, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
665
0
TUA人資客服組
2022-06-07
2.70
MP07-10: Hypertension as a risk factor for urinary retention in the acute stage of the middle cerebral artery stroke
人氣: 665, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
763
0
TUA人資客服組
2022-06-07
2.71
MP08-01: Hyperthermia enhances chemosensitivity of bladder cancer through epithelial mesenchymal transition suppression
人氣: 763, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
545
0
TUA人資客服組
2022-06-07
2.72
MP08-02: External validation of pre-operative nomogram for prediction of non-organ confined upper urinary tract urothelial carcinoma in central Taiwan population
人氣: 545, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
558
0
TUA人資客服組
2022-06-07
2.73
MP08-03: The characteristics of end stage renal disease patients with upper urinary tract urothelial cancer treated with radical nephroureterectomy: A single center experience
人氣: 558, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
551
0
TUA人資客服組
2022-06-07
2.74
MP08-04: Investigate the role of neutrophil in different phenotypes of upper tract urothelial carcinoma
人氣: 551, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
537
0
TUA人資客服組
2022-06-07
2.75
MP08-05: Prevalence of chronic kidney disease in upper tract urothelial carcinoma endemic area and its oncological impact in real world
人氣: 537, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
567
0
TUA人資客服組
2022-06-07
2.76
MP08-06: The prognostic impact of tumor location in pT3N0M0 upper urinary tract urothelial carcinoma
人氣: 567, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
604
0
TUA人資客服組
2022-06-07
2.77
MP08-07: Therapeutic outcome of radiation therapy for postoperative locoregional recurrence of upper tract urothelial carcinoma
人氣: 604, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
603
0
TUA人資客服組
2022-06-07
2.78
MP08-08: The impact of nutrition status and comorbidity on the prognosis of upper urinary tract urothelial carcinoma
人氣: 603, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
528
0
TUA人資客服組
2022-06-07
2.79
MP08-09: Comparison of the molecular characteristics of chemical-induced rat interstitial cystitis models
人氣: 528, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
558
0
TUA人資客服組
2022-06-07
2.80
MP08-10: Clinical outcomes of partial resection and replantation of peritoneal dialysis catheter in end stage renal disease patients under continuous ambulatory peritoneal dialysis
人氣: 558, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
3.
Non-Discussion Poster
647
0
TUA人資客服組
2022-06-07
3.1
NDP001: Adrenal cortical carcinoma with IVC/RA thrombus—case report
人氣: 647, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
765
0
TUA人資客服組
2022-06-07
3.2
NDP002: Results of lenvatinib plus pembrolizumab as neoadjuvant therapy before definite surgery in patients with advanced renal cell carcinoma
人氣: 765, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
493
0
TUA人資客服組
2022-06-07
3.3
NDP003: Malignant renal epithelioid angiomyolipoma with vaginal and pulmonary metastases – case report
人氣: 493, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
500
0
TUA人資客服組
2022-06-07
3.4
NDP004: Rare differential diagnosis of hemoperitoneum: A case report and review of atraumatic ruptured renal tumor
人氣: 500, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
542
0
TUA人資客服組
2022-06-07
3.5
NDP005: Sporadic extraneural hemangioblastoma associated with polycythemia
人氣: 542, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
531
0
TUA人資客服組
2022-06-07
3.6
NDP006: Bad-luck but good outcome: The clinical implications of synchronous prostate cancer and renal cell carcinoma in 5 cases
人氣: 531, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
677
0
TUA人資客服組
2022-06-07
3.7
NDP007: Malakoplakia in a patient with multiple myeloma – a rare case report
人氣: 677, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
525
0
TUA人資客服組
2022-06-07
3.8
NDP008: Skin metastasis of renal pelvic squamous cell carcinoma: A case report and literature review
人氣: 525, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
669
0
TUA人資客服組
2022-06-07
3.9
NDP009: Nivolumab and ipilimumab combination therapy in metastasis adrenocortical carcinoma patient: A case report
人氣: 669, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
622
0
TUA人資客服組
2022-06-07
3.10
NDP010: Renal glomus tumor: A case report and literature review
人氣: 622, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
530
0
TUA人資客服組
2022-06-07
3.11
NDP011: The surgical intervention and outcome of pheochromocytoma crisis: A case series from one single tertiary medical center
人氣: 530, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
597
0
TUA人資客服組
2022-06-07
3.12
NDP012: Silicone granuloma of penis
人氣: 597, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
482
0
TUA人資客服組
2022-06-07
3.13
NDP013: Rare prostatic tumor: Multilocular prostatic cystadenoma
人氣: 482, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
756
0
TUA人資客服組
2022-06-07
3.14
NDP014: Intravascular papillary endothelial hyperplasia (Masson tumor) of testis: Case report
人氣: 756, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
505
0
TUA人資客服組
2022-06-07
3.15
NDP015: Testicular myeloid sarcoma: A case report
人氣: 505, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
489
0
TUA人資客服組
2022-06-07
3.16
NDP016: Pheochromocytoma with brain metastasis presenting with compressive optic neuropathy--a rare case report
人氣: 489, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
496
0
TUA人資客服組
2022-06-07
3.17
NDP017: Castleman’s disease mimicking renal cell carcinoma: A case report
人氣: 496, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
534
0
TUA人資客服組
2022-06-07
3.18
NDP018: Rare cases report: angiomyolipoma with aggressive behavior of venous invasion
人氣: 534, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
478
0
TUA人資客服組
2022-06-07
3.19
NDP019: Pelvic solitary fibrous tumor- a case report and review of literature
人氣: 478, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
517
0
TUA人資客服組
2022-06-07
3.20
NDP020: Extensive radical surgery and flap reconstruction for recurrent urethra adenocarcinoma: A case report
人氣: 517, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
592
0
TUA人資客服組
2022-06-07
3.21
NDP021: Ureteral paraganglioma: A rare case report
人氣: 592, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
511
0
TUA人資客服組
2022-06-07
3.22
NDP022: Urethral melanoma case presentation and review on latest guidelines
人氣: 511, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
628
0
TUA人資客服組
2022-06-07
3.23
NDP023: Malacoplakia of the urinary bladder with escherichia coli infection: A case report and review of the literature
人氣: 628, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
518
0
TUA人資客服組
2022-06-07
3.24
NDP024: Neuroendocrine carcinoma of urinary bladder in the past ten years in a single hospital- a case series
人氣: 518, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
518
0
TUA人資客服組
2022-06-07
3.25
NDP025: Pheochromocytoma-related takusubo cardiomyopathy during transurethral enucleation of prostate - a case report
人氣: 518, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
560
0
TUA人資客服組
2022-06-07
3.26
NDP026: Malignant sertoli cell tumor of testis: A rare case report
人氣: 560, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
779
0
TUA人資客服組
2022-06-07
3.27
NDP027: An extraordinarily huge retroperitoneal liposarcoma: A case report and literature review
人氣: 779, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
642
0
TUA人資客服組
2022-06-07
3.28
NDP028: Spermatic cord liposarcoma presenting as recurrent inguinal hernia– a case report
人氣: 642, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
553
0
TUA人資客服組
2022-06-07
3.29
NDP029: Urachal adenocarcinoma with bone and lung metastases: A rare case report and literature review
人氣: 553, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
517
0
TUA人資客服組
2022-06-07
3.30
NDP030: Dedifferentiated liposarcomas of spermatic cord- a review and case report
人氣: 517, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
719
0
TUA人資客服組
2022-06-07
3.31
NDP031: A 15-year change of adrenal endothelial cyst
人氣: 719, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
538
0
TUA人資客服組
2022-06-07
3.32
NDP032: A rare case of eosinophilic cystitis mimic urothelial tumor
人氣: 538, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
497
0
TUA人資客服組
2022-06-07
3.33
NDP033: A case report: primary bladder adenocarcinoma with concurrent urachal cyst and adenocarcinoma
人氣: 497, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
504
0
TUA人資客服組
2022-06-07
3.34
NDP034: A rare benign tumor of intrascroal lipoblastoma: a case report and literature review
人氣: 504, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
577
0
TUA人資客服組
2022-06-07
3.35
NDP035: Sertoli cell tumor of testis: Case report and review of the literature
人氣: 577, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
529
0
TUA人資客服組
2022-06-07
3.36
NDP036: Female urethral hemangioma misdiagnosed as a vaginal tumor: A case report and review
人氣: 529, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
631
0
TUA人資客服組
2022-06-07
3.37
NDP037: KCGMH experience and meta-analysis: Comparing PSA response of Abiraterone and Enzalutamide in metastatic castration-resistant prostate cancer in real-world practice
人氣: 631, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
563
0
TUA人資客服組
2022-06-07
3.38
NDP038: The efficacy of enhanced recovery after surgery (ERAS) in radical prostatectomy
人氣: 563, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
800
0
TUA人資客服組
2022-06-07
3.39
NDP039: The risk factors of the stress urinary incontinence after robotic-assisted laparoscopic radical prostatectomy
人氣: 800, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
500
0
TUA人資客服組
2022-06-07
3.40
NDP040: Hormone therapy for prostate cancer increased the risk of subsequent hypertension: A nationwide longitudinal cohort study
人氣: 500, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
495
0
TUA人資客服組
2022-06-07
3.41
NDP041: Association between 5α-reductase inhibitors and androgen deprivation therapy
人氣: 495, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
456
0
TUA人資客服組
2022-06-07
3.42
NDP042: The prevalence of port-site incisional hernia after urologic robot-assisted laparoscopic surgery: A single-center retrospective study
人氣: 456, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
557
0
TUA人資客服組
2022-06-07
3.43
NDP043: Comparison of chemotherapy and androgen receptor targeted agents as sequencing treatment in castration resistance prostate cancer
人氣: 557, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
512
0
TUA人資客服組
2022-06-07
3.44
NDP044: Primary malignant melanoma of prostatic urethral: A rare case report and literature review
人氣: 512, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
507
0
TUA人資客服組
2022-06-07
3.45
NDP045: The graft ureteral cancer: A surgical method of graft kidney preservation and planning for future upper tract follow-up
人氣: 507, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
567
0
TUA人資客服組
2022-06-07
3.46
NDP046: Tumor origin of the graft ureteral cancer: From recipient or donor?
人氣: 567, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
548
0
TUA人資客服組
2022-06-07
3.47
NDP047: Urothelial carcinoma recurrence in graft kidney: Case report and literature review
人氣: 548, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
609
0
TUA人資客服組
2022-06-07
3.48
NDP048: Metastatic urothelial carcinoma to skull with significant reossification after pembrolizumab: A case report
人氣: 609, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
467
0
TUA人資客服組
2022-06-07
3.49
NDP049: Extremely rare but rapidly aggressive sarcomatoid urothelial carcinoma: A case report and literature review
人氣: 467, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
534
0
TUA人資客服組
2022-06-07
3.50
NDP050: The postoperative clinical course of bladder cancer with pathological stage T2 low grade after radical cystectomy: A case report of 15-year-outcome
人氣: 534, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
590
0
TUA人資客服組
2022-06-07
3.51
NDP051: Laparoscopic partial cystectomy for the management of urothelial carcinoma in bladder diverticulum
人氣: 590, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
518
0
TUA人資客服組
2022-06-07
3.52
NDP052: Highly invasive and refractory epithelioid angiomyolipoma with liver and lung metastasis: A rare case report and literature review
人氣: 518, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
534
0
TUA人資客服組
2022-06-07
3.53
NDP053: The unusual clinical and image presentation of huge bladder tumor (more than 500 grams) without gross hematuria.
人氣: 534, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
508
0
TUA人資客服組
2022-06-07
3.54
NDP054: The clinical presentation and treatment outcome of Mtor inhibitor in epithelioid angiomyolipoma : A case report and literature review
人氣: 508, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
514
0
TUA人資客服組
2022-06-07
3.55
NDP055: Surgical intervention and immunotherapy for locally advanced plasmacytoid urothelial carcinoma of urinary bladder: A case report
人氣: 514, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
537
0
TUA人資客服組
2022-06-07
3.56
NDP056: Case report: bladder tumor presented with urethral bleeding
人氣: 537, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
522
0
TUA人資客服組
2022-06-07
3.57
NDP057: Fifteen-centimeter-long penile urethral stricture rescued by buccal mucosa graft urethroplasty- a rare case report
人氣: 522, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
488
0
TUA人資客服組
2022-06-07
3.58
NDP058: Endoscopic transurethral fulguration for acute urine retention resulting from a huge bladder diverticulum: A case report
人氣: 488, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
534
0
TUA人資客服組
2022-06-07
3.59
NDP059: Gas explosion during transurethral resection of prostate(TURP) result in bladder rupture: Case report
人氣: 534, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
583
0
TUA人資客服組
2022-06-07
3.60
NDP060: Urolithiasis in unilateral duplex kidney with complete duplicated ureters
人氣: 583, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
504
0
TUA人資客服組
2022-06-07
3.61
NDP061: The application of antegrade flexible ureteroscopy(Furs) for difficult ureter stone scenario: Kidney transplantation and urinary diversion
人氣: 504, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
660
0
TUA人資客服組
2022-06-07
3.62
NDP062: Complete staghorn stone of rotated duplicated-pelvicalyceal horseshoe kidney
人氣: 660, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
554
0
TUA人資客服組
2022-06-07
3.63
NDP063: Distal ureteral stone in a Studer orthotopic neobladder: A case treated by antegrade flexible cystoscopic and flexible ureteroscopic lithotripsy
人氣: 554, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
515
0
TUA人資客服組
2022-06-07
3.64
NDP064: Pubic hair nidus of bladder stones in a catheterized female patient: A case report and literature review
人氣: 515, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
523
0
TUA人資客服組
2022-06-07
3.65
NDP065: Ureteroscopic lithotripsy related renal pseudoaneurysm- a rare complication after a common operation
人氣: 523, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
633
0
TUA人資客服組
2022-06-07
3.66
NDP066: An adult male ureterocele combines with complicated stone: A case report and literature review
人氣: 633, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
538
0
TUA人資客服組
2022-06-07
3.67
NDP067: Migration of Hem-O-Lok mimicking distal ureteral stone following robotic partial nephrectomy: A case report with review of literature
人氣: 538, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
545
0
TUA人資客服組
2022-06-07
3.68
NDP068: Bladder stone forming on migrated surgical clip ten years after robotic-assisted radical prostatectomy: A case report and literature review
人氣: 545, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
531
0
TUA人資客服組
2022-06-07
3.69
NDP069: Minimal invasive surgery for the treatment of ureteral endometriosis related obstructive uropathy – a single-center experience
人氣: 531, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
562
0
TUA人資客服組
2022-06-07
3.70
NDP070: Chylous ascites after robot-assisted laparoscopic radical prostatectomy
人氣: 562, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
567
0
TUA人資客服組
2022-06-07
3.71
NDP071: V-loc associated intestinal obstruction: A noteworthy cause of postoperative ileus after robotic assisted radical prostatectomy
人氣: 567, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
666
0
TUA人資客服組
2022-06-07
3.72
NDP072: Tuberculous epididymo-orchitis caused by intravesical bacillus calmette-guérin immunotherapy for bladder cancer: A case report
人氣: 666, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
705
0
TUA人資客服組
2022-06-07
3.73
NDP073: A case report: Xanthogranulomatous cystitis masquerading bladder tumor
人氣: 705, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
711
0
TUA人資客服組
2022-06-07
3.74
NDP074: Diluted iodine aqueous bladder instillations change the antibiotic susceptibility from multiple drug resistance microorganisms in catheter-associated urinary tract infection
人氣: 711, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
543
0
TUA人資客服組
2022-06-07
3.75
NDP075: Xanthogranulomatous epididymitis as a rare cause of chronic scrotal pain – case report and review of literature
人氣: 543, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
546
0
TUA人資客服組
2022-06-07
3.76
NDP076: Necrotizing fasciitis after extracorporeal shock wave lithotripsy: A case report
人氣: 546, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
802
0
TUA人資客服組
2022-06-07
3.77
NDP077: Complications of disposable circumcision suture device necessitating surgical intervention: A case series
人氣: 802, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
569
0
TUA人資客服組
2022-06-07
3.78
NDP078: Urachus fistula: A rare first presentation of appendicitis
人氣: 569, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
568
0
TUA人資客服組
2022-06-07
3.79
NDP079: Repeat acute pyelonephritis caused by an ureterocele: A case report and literature review
人氣: 568, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
583
0
TUA人資客服組
2022-06-07
3.80
NDP080: Intratesticular hematoma from blunt trauma, a case report about experience of emergency surgical exploration and literature review
人氣: 583, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
675
0
TUA人資客服組
2022-06-07
3.81
NDP081: A bladder-sparing surgical technique for recurrent enterovesical fistula
人氣: 675, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
572
0
TUA人資客服組
2022-06-07
3.82
NDP082: Traumatic rupture of hydrocele: Case report and review of the literature
人氣: 572, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
571
0
TUA人資客服組
2022-06-07
3.83
NDP083: Paraganglioma of the urinary bladder: A case report
人氣: 571, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
572
0
TUA人資客服組
2022-06-07
3.84
NDP084: Prolapsed ureterocele causing acute pain and urine retention: A case report
人氣: 572, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
800
0
TUA人資客服組
2022-06-07
3.85
NDP085: Appendix testis torsion in young male with retractile testis and absence blood flow in color doppler ultrasound – a case report
人氣: 800, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
562
0
TUA人資客服組
2022-06-07
3.86
NDP086: Pulmonary embolism after moderna vaccination in kidney transplant: two-case reports and literature review
人氣: 562, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
537
0
TUA人資客服組
2022-06-07
3.87
NDP087: None A: type renal amyloidosis complicated with staghorn renal stone – a case report
人氣: 537, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
695
0
TUA人資客服組
2022-06-07
3.88
NDP088: Delayed retroperitoneal abscess with cutaneous fistula after nephrectomy with inferior vena cava graft reconstruction: A case report
人氣: 695, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
719
0
TUA人資客服組
2022-06-07
3.89
NDP089: Scrotal wall ischemia change following the COVID-19 vaccine: A first case report
人氣: 719, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
549
0
TUA人資客服組
2022-06-07
3.90
NDP090: Right renal infarction after an aortocaval tumor excision – a rare case report
人氣: 549, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
645
0
TUA人資客服組
2022-06-07
3.91
NDP091: Migration of a ventriculo-peritoneal shunt into the urinary bladder- a rare case report and management
人氣: 645, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
693
0
TUA人資客服組
2022-06-07
3.92
NDP092: The american association F for the surgery of trauma association grade V renal blunt trauma successfully treated conservatively: A case report and imaging sharing
人氣: 693, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
663
0
TUA人資客服組
2022-06-07
3.93
NDP093: Igg4-related retroperitoneal fibrosis causing ureter stricture and hydronephrosis: A rare case report
人氣: 663, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
605
0
TUA人資客服組
2022-06-07
3.94
NDP094: Renal arteriovenous fistula presenting with acute pyelonephritis: A rare case report
人氣: 605, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
612
0
TUA人資客服組
2022-06-07
3.95
NDP096: Endometriosis mimic urachal tumor
人氣: 612, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
891
0
TUA人資客服組
2022-06-07
3.96
NDP097: Kidney laceration after acupuncture and tuina: A case report
人氣: 891, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
636
0
TUA人資客服組
2022-06-07
3.97
NDP098: Spontaneous renal rupture resulted from severe hydronephrosis associated with ureteral obstruction: A case report
人氣: 636, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
593
0
TUA人資客服組
2022-06-07
3.98
NDP099: Mantle cell lymphoma initial presenting as bilateral inguinal mass
人氣: 593, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
567
0
TUA人資客服組
2022-06-07
3.99
NDP100: Solitary fibrous tumor: A rare inguinal tumor
人氣: 567, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07